BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27725729)

  • 1. Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?
    Murphy AB; Nyame YA; Batai K; Kalu R; Khan A; Gogana P; Dixon M; Macias V; Kajdacsy-Balla A; Hollowell CM; Catalona WJ; Kittles R
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):55-60. PubMed ID: 27725729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.
    Roehrborn CG; Andriole GL; Wilson TH; Castro R; Rittmaster RS
    Eur Urol; 2011 Feb; 59(2):244-9. PubMed ID: 21093145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia.
    Zhang W; Zheng X; Wang Y; Xiao H
    Urology; 2016 Nov; 97():212-218. PubMed ID: 27327576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D deficiency predicts prostate biopsy outcomes.
    Murphy AB; Nyame Y; Martin IK; Catalona WJ; Hollowell CM; Nadler RB; Kozlowski JM; Perry KT; Kajdacsy-Balla A; Kittles R
    Clin Cancer Res; 2014 May; 20(9):2289-99. PubMed ID: 24789033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy.
    Nyame YA; Murphy AB; Bowen DK; Jordan G; Batai K; Dixon M; Hollowell CM; Kielb S; Meeks JJ; Gann PH; Macias V; Kajdacsy-Balla A; Catalona WJ; Kittles R
    J Clin Oncol; 2016 Apr; 34(12):1345-9. PubMed ID: 26903577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low 25-OH vitamin D is associated with benign prostatic hyperplasia.
    Haghsheno MA; Mellström D; Behre CJ; Damber JE; Johansson H; Karlsson M; Lorentzon M; Peeker R; Barret-Connor E; Waern E; Sundh V; Ohlsson C; Hammarsten J
    J Urol; 2013 Aug; 190(2):608-14. PubMed ID: 23399651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
    Haese A; Graefen M; Steuber T; Becker C; Noldus J; Erbersdobler A; Huland E; Huland H; Lilja H
    J Urol; 2003 Dec; 170(6 Pt 1):2269-73. PubMed ID: 14634394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The incidence of lesions associated with prostatic biopsy and its effect on the serum concentration of the prostate-specific antigen].
    Morote Robles J; López López M; Encabo Duro G; de Torres Ramírez I
    Actas Urol Esp; 1999 May; 23(5):400-5. PubMed ID: 10427813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes.
    Caretta N; Vigili de Kreutzenberg S; Valente U; Guarneri G; Pizzol D; Ferlin A; Avogaro A; Foresta C
    Andrology; 2015 Nov; 3(6):1062-7. PubMed ID: 26339755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate biopsy in patients with long-term use of indwelling bladder catheter: what is the rationale?
    Antunes AA; Barbosa JA; Reis ST; Guariero MS; Fukushima JT; Dall'oglio MF; Freire Gde C; Lucon AM; Leite KR; Srougi M
    Urol Oncol; 2012 Sep; 30(5):620-3. PubMed ID: 20933446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indonesian prostate cancer risk calculator (IPCRC): an application for predicting prostate cancer risk (a multicenter study).
    Yuri P; Wangge G; Abshari F; Satjakoesoemah AI; Perdana NR; Wijaya CD; Tansol C; Tigor A; Safriadi F; Kadar DD; Warli SM; Rochadi S; Danarto ; Hakim L; Djatisoesanto W; Hardjowijoto S; Mochtar CA; Umbas R; Hamid AR
    Acta Med Indones; 2015 Apr; 47(2):95-103. PubMed ID: 26260551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
    Ornstein DK; Rao GS; Smith DS; Andriole GL
    J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL.
    Kobayashi T; Mitsumori K; Kawahara T; Nishizawa K; Ogura K; Ide Y
    Int J Urol; 2005 Nov; 12(11):969-75. PubMed ID: 16351653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy.
    Janbaziroudsari H; Mirzaei A; Maleki N
    Bull Cancer; 2016 Sep; 103(9):730-4. PubMed ID: 27345449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate biopsy findings in Indian men: a hospital-based study.
    Sinha S; Siriguri SR; Kanakmedala SK; Bikkasani K
    Indian J Cancer; 2011; 48(2):175-80. PubMed ID: 21768662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.
    Al-Azab R; Toi A; Lockwood G; Kulkarni GS; Fleshner N
    Urology; 2007 Jan; 69(1):103-7. PubMed ID: 17270628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.